We thus wondered whether the PHF19-dependent control of p21 was a consistent mechanism for cell cycle modulation at the bone marrow of CML patients, where most cycling cells are found. This evidence concerns the gene CDKN1A and chronic myelogenous leukemia, BCR-ABL1 positive.